14% Revenue and 8% Orders Growth in Q4; Company issues FY25 GuidanceMADISON, Wis., Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024.Fourth Quarter Fiscal 2024 SummaryNet revenue of $134.3 million, an increase of 13.5 percent from the same period in the prior fiscal year. Net revenue on a constant currency basis was $136.7 million, which represents a 15.6 percent increase versus the same period in th ...

Exhibit 99.1 Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results 14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wisconsin, August 14, 2024 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024. Fourth Quarter Fiscal 2024 Summary • Net revenue of $134.3 million, an increase of 13.5 percent from the same period in the prior fiscal year. Net revenue on a constant currency basis was $136.7 mi ...

New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy TreatmentsMADISON, Wis. and DAYTONA BEACH, Fla., Aug. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Halifax Health, in Volusia County, Florida, announced today that the Charles L. and Miki N. Grant Cancer Center for Hope medical team is the first in the U.S. to treat cancer patients using the Accuray Radixact® System with VitalHold™* techn ...

MADISON, Wis., July 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2024, ended June 30, 2024, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 14, 2024.The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. Th ...

When it comes to investing in top penny stocks, a word of caution.Always do your due diligence before buying. Make sure it has volume. Know upfront that you can lose a lot of money. And don’t get caught up in the promotional promises of turning $10,000 into millions without first doing your homework. As I’ll repeat below, penny stocks are frequently the playground for scam artists and market manipulators.Sure, some penny stocks turned out to be massive success stories, like Apple (NASDAQ:AAPL), Ford (NYSE:F ...

The Radixact System will be supplied with ClearRT®, Synchrony®, and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speedHeidelberg University Hospital is recognized worldwide for excellence in patient care and practice changing researchMADISON, Wis., June 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company's Radixact® System, equipped with its prop ...

Accuray Incorporated (ARAY) recently announced an agreement with TrueNorth Medical Physics LLC, a private company offering radiation oncology consultancy to radiation oncology departments external help aimed to improve the capabilities of the departments.Under the terms of the agreement, TrueNorth is likely to offer services that are complementary and supplementary to the services provided by Accuray, acting as an extension of the hospital team. This will enable hospitals to ensure that it has the staffing ...

MADISON, Wis., June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities. Under the terms of the agreement, TrueNorth Medical Physics will offer services that are complementary and supplementary to those supplied by Accuray, acting as an extension of the hospital team – on-site, remote or hybrid – to help ensure they ha ...

Accuray Incorporated (ARAY) recently announced that the Chinese National Medical Products Administration (NMPA) approved the registration dossier of the Accuray Precision Treatment Planning System (TPS).The CNNC-Accuray joint venture Tomo C radiation therapy system and the Accuray Precision TPS are now compatible. These are likely to provide medical teams with a new way to administer highly accurate and precise radiation treatments, as well as expand access to care for more cancer patients in China.More on ...

MADISON, Wis., June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA). The Accuray Precision TPS is now available for use with the CNNC-Accuray joint venture Tomo® C radiation therapy system and in combination, will provide medical care teams with a new option for delivering extremely precise and accurate radiothe ...